Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
MY TRIALS
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Register a trial
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT05297448
Registration number
NCT05297448
Ethics application status
Date submitted
17/03/2022
Date registered
28/03/2022
Titles & IDs
Public title
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Query!
Scientific title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Query!
Secondary ID [1]
0
0
RNLC3132
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
RED-C-3132
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Hepatic Encephalopathy
0
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
0
0
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Neurological
0
0
0
0
Query!
Other neurological disorders
Query!
Metabolic and Endocrine
0
0
0
0
Query!
Other metabolic disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - Rifaximin SSD
Treatment: Drugs - Placebo
Experimental: Rifaximin SSD-40mg IR -
Placebo comparator: Placebo -
Treatment: Drugs: Rifaximin SSD
Rifaximin Solid Soluble Dispersion Immediate Release Twice Daily
Treatment: Drugs: Placebo
Placebo Twice Daily
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Time to first event of overt hepatic encephalopathy requiring hospitalization
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
72 weeks
Query!
Secondary outcome [1]
0
0
Time to first Conn score = 2
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
72 weeks
Query!
Secondary outcome [2]
0
0
Time to all-cause hospitalization
Query!
Assessment method [2]
0
0
Query!
Timepoint [2]
0
0
72 weeks
Query!
Secondary outcome [3]
0
0
Time to first event of OHE that requires hospitalization, or all-cause death
Query!
Assessment method [3]
0
0
Query!
Timepoint [3]
0
0
72 weeks
Query!
Eligibility
Key inclusion criteria
Key
* Diagnosis of liver cirrhosis with medically controlled ascites (>30 days) not requiring therapeutic paracentesis (could have had paracentesis in the past).
* Conn (West Haven Criteria) score of < 2.
* Mini-Mental State Examination (MMSE) score > 24 at screening.
* = 18 and = 85 years of age.
Key
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
85
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Active COVID-19 that is unresolved
* History of SBP
* History of EVB or AKI-HRS within 6 months
* History of OHE episode (Conn score = 2)
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
3/08/2022
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
1/01/2026
Query!
Actual
Query!
Sample size
Target
466
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
0
0
Bausch Site 709 - Camperdown
Query!
Recruitment hospital [2]
0
0
Bausch Site 710 - Westmead
Query!
Recruitment postcode(s) [1]
0
0
2050 - Camperdown
Query!
Recruitment postcode(s) [2]
0
0
2145 - Westmead
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Alabama
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Arizona
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
California
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Colorado
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Florida
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Georgia
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Illinois
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Indiana
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Iowa
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Kansas
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Louisiana
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Maryland
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Mississippi
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Missouri
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
New Jersey
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
New York
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
North Carolina
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
Ohio
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
Pennsylvania
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
Rhode Island
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
South Carolina
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
Tennessee
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
Texas
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
Vermont
Query!
Country [25]
0
0
United States of America
Query!
State/province [25]
0
0
Virginia
Query!
Country [26]
0
0
Belgium
Query!
State/province [26]
0
0
Antwerpen
Query!
Country [27]
0
0
Belgium
Query!
State/province [27]
0
0
Genk
Query!
Country [28]
0
0
Belgium
Query!
State/province [28]
0
0
Gent
Query!
Country [29]
0
0
Belgium
Query!
State/province [29]
0
0
Kortrijk
Query!
Country [30]
0
0
Belgium
Query!
State/province [30]
0
0
Liege
Query!
Country [31]
0
0
Belgium
Query!
State/province [31]
0
0
Mechelen
Query!
Country [32]
0
0
Bulgaria
Query!
State/province [32]
0
0
Ruse
Query!
Country [33]
0
0
Bulgaria
Query!
State/province [33]
0
0
Sliven
Query!
Country [34]
0
0
Bulgaria
Query!
State/province [34]
0
0
Sofia
Query!
Country [35]
0
0
Bulgaria
Query!
State/province [35]
0
0
Stara Zagora
Query!
Country [36]
0
0
Canada
Query!
State/province [36]
0
0
Alberta
Query!
Country [37]
0
0
Canada
Query!
State/province [37]
0
0
British Columbia
Query!
Country [38]
0
0
Canada
Query!
State/province [38]
0
0
Ontario
Query!
Country [39]
0
0
Canada
Query!
State/province [39]
0
0
Quebec
Query!
Country [40]
0
0
France
Query!
State/province [40]
0
0
Angers
Query!
Country [41]
0
0
France
Query!
State/province [41]
0
0
Belfort
Query!
Country [42]
0
0
France
Query!
State/province [42]
0
0
Besançon
Query!
Country [43]
0
0
France
Query!
State/province [43]
0
0
Clermont-Ferrand
Query!
Country [44]
0
0
France
Query!
State/province [44]
0
0
Limoges
Query!
Country [45]
0
0
France
Query!
State/province [45]
0
0
Lyon
Query!
Country [46]
0
0
France
Query!
State/province [46]
0
0
Nice
Query!
Country [47]
0
0
France
Query!
State/province [47]
0
0
Paris
Query!
Country [48]
0
0
France
Query!
State/province [48]
0
0
Pessac
Query!
Country [49]
0
0
France
Query!
State/province [49]
0
0
Rennes
Query!
Country [50]
0
0
France
Query!
State/province [50]
0
0
Toulouse
Query!
Country [51]
0
0
France
Query!
State/province [51]
0
0
VandÅ“uvre-lès-Nancy
Query!
Country [52]
0
0
France
Query!
State/province [52]
0
0
Villejuif
Query!
Country [53]
0
0
Germany
Query!
State/province [53]
0
0
Berlin
Query!
Country [54]
0
0
Hungary
Query!
State/province [54]
0
0
Budapest
Query!
Country [55]
0
0
Hungary
Query!
State/province [55]
0
0
Debrecen
Query!
Country [56]
0
0
India
Query!
State/province [56]
0
0
Belgaum
Query!
Country [57]
0
0
India
Query!
State/province [57]
0
0
Mangaluru
Query!
Country [58]
0
0
India
Query!
State/province [58]
0
0
Nagpur
Query!
Country [59]
0
0
India
Query!
State/province [59]
0
0
Nashik
Query!
Country [60]
0
0
India
Query!
State/province [60]
0
0
Secunderabad
Query!
Country [61]
0
0
India
Query!
State/province [61]
0
0
Surat
Query!
Country [62]
0
0
Italy
Query!
State/province [62]
0
0
Milano
Query!
Country [63]
0
0
Italy
Query!
State/province [63]
0
0
Napoli
Query!
Country [64]
0
0
Italy
Query!
State/province [64]
0
0
Novara
Query!
Country [65]
0
0
Italy
Query!
State/province [65]
0
0
Palermo
Query!
Country [66]
0
0
Italy
Query!
State/province [66]
0
0
Rozzano
Query!
Country [67]
0
0
Korea, Republic of
Query!
State/province [67]
0
0
Busan
Query!
Country [68]
0
0
Korea, Republic of
Query!
State/province [68]
0
0
Daegu
Query!
Country [69]
0
0
Korea, Republic of
Query!
State/province [69]
0
0
Daejeon
Query!
Country [70]
0
0
Korea, Republic of
Query!
State/province [70]
0
0
Gangwon-do
Query!
Country [71]
0
0
Korea, Republic of
Query!
State/province [71]
0
0
Goyang-si
Query!
Country [72]
0
0
Korea, Republic of
Query!
State/province [72]
0
0
Gyeonggi-do
Query!
Country [73]
0
0
Korea, Republic of
Query!
State/province [73]
0
0
Gyeongsang
Query!
Country [74]
0
0
Korea, Republic of
Query!
State/province [74]
0
0
Seongnam-si
Query!
Country [75]
0
0
Korea, Republic of
Query!
State/province [75]
0
0
Seoul
Query!
Country [76]
0
0
Korea, Republic of
Query!
State/province [76]
0
0
Yongin-si
Query!
Country [77]
0
0
Mongolia
Query!
State/province [77]
0
0
Ulaan Baatar
Query!
Country [78]
0
0
New Zealand
Query!
State/province [78]
0
0
Christchurch
Query!
Country [79]
0
0
New Zealand
Query!
State/province [79]
0
0
Grafton
Query!
Country [80]
0
0
New Zealand
Query!
State/province [80]
0
0
Hamilton
Query!
Country [81]
0
0
Poland
Query!
State/province [81]
0
0
Bydgoszcz
Query!
Country [82]
0
0
Poland
Query!
State/province [82]
0
0
Katowice
Query!
Country [83]
0
0
Poland
Query!
State/province [83]
0
0
Kraków
Query!
Country [84]
0
0
Poland
Query!
State/province [84]
0
0
Myslowice
Query!
Country [85]
0
0
Poland
Query!
State/province [85]
0
0
Staszów
Query!
Country [86]
0
0
Poland
Query!
State/province [86]
0
0
Wroclaw
Query!
Country [87]
0
0
Puerto Rico
Query!
State/province [87]
0
0
Guaynabo
Query!
Country [88]
0
0
Puerto Rico
Query!
State/province [88]
0
0
San Juan
Query!
Country [89]
0
0
Spain
Query!
State/province [89]
0
0
Barcelona
Query!
Country [90]
0
0
Spain
Query!
State/province [90]
0
0
Madrid
Query!
Country [91]
0
0
Spain
Query!
State/province [91]
0
0
Málaga
Query!
Country [92]
0
0
Spain
Query!
State/province [92]
0
0
Pontevedra
Query!
Country [93]
0
0
Spain
Query!
State/province [93]
0
0
Valencia
Query!
Country [94]
0
0
Spain
Query!
State/province [94]
0
0
Zaragoza
Query!
Country [95]
0
0
United Kingdom
Query!
State/province [95]
0
0
Dundee
Query!
Country [96]
0
0
United Kingdom
Query!
State/province [96]
0
0
Hull
Query!
Country [97]
0
0
United Kingdom
Query!
State/province [97]
0
0
Liverpool
Query!
Country [98]
0
0
United Kingdom
Query!
State/province [98]
0
0
Nottingham
Query!
Country [99]
0
0
United Kingdom
Query!
State/province [99]
0
0
Plymouth
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Bausch Health Americas, Inc.
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
Study RNLC3132 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by the presence of medically controlled ascites.
Query!
Trial website
https://clinicaltrials.gov/study/NCT05297448
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Michael Mader
Query!
Address
0
0
Bausch Health
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Undecided
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT05297448